Written answers

Wednesday, 6 March 2019

Department of Health

Medicinal Products Availability

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

206. To ask the Minister for Health if a detailed analysis of the decision not to make Spinraza available to persons here will be provided including but not limited to the final agreed costs to the HSE and the final agreed costs in all other relevant jurisdictions; if the costs for Ireland are broadly comparable to all other jurisdictions in which Spinraza is being made available; the rationale for it not being made available here; and if he will make a statement on the matter. [11180/19]

Photo of Simon HarrisSimon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Comments

No comments

Log in or join to post a public comment.